NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 10 filers reported holding NLS PHARMACEUTICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tower Research Capital LLC (TRC) | 36,525 | $148,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Clearstead Advisors, LLC | 300 | $1,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 33,213 | $134,000 | 0.00% |